Lorazepam for the Treatment of Status Epilepticus in Children

Phase 1 Completed 69 enrolled Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) The Emmes Company, LLC · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to gather the data to: 1) determine the best dose, and 2) evaluate its effectiveness and safety in stopping seizures. Part 1 is a pharmacokinetic study (study of how much drug is found in the body after it is given through a vein and how fast the body gets rid of the drug).

Timeline

Start: 2005-03
Primary completion: 2007-04
Completion: 2009-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lorazepam	Small molecule	—	Intravenous

Indications

No indication recorded.